AMRX EV/EBITDA
14.30
-0.31-2.12%
Wed, 22 Jan 2025 22:45:25 GMT
Summary:
As of January 23, 2025, AMRX EV/EBITDA is 14.30, with a fall of -0.31 (-2.12%) during the most recent trading day. Over the past year, it has increased by +3.22 (+29.06%). AMRX EV/EBITDA is now -88.54% below its all-time high of 124.82.AMRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -2.1% |
1 m1 month | +2.5% |
3 m3 months | -1.0% |
6 m6 months | +2.4% |
ytdytd | +3.0% |
1 y1 year | +29.1% |
5 y5 years | -34.2% |
AMRX EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | 14.61 | -2.1% | 13.76 | +3.9% |
3 m | 3-month | 14.91 | -4.1% | 13.71 | +4.3% |
6 m | 6-month | 15.40 | -7.1% | 13.51 | +5.8% |
1 y | 1-year | 15.40 | -7.1% | 10.69 | +33.8% |
3 y | 3-year | 29.13 | -50.9% | 6.97 | +105.2% |
5 y | 5-year | 29.13 | -50.9% | 6.97 | +105.2% |
alltime | all time | 124.82 | -88.5% | -90.04 | +115.9% |
Amneal Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | 14.30(+3.0%) |
2024 | 13.89(+22.8%) |
2023 | 11.31(-45.5%) |
2022 | 20.74(+148.7%) |
Date | Value |
---|---|
2021 | 8.34(-12.1%) |
2020 | 9.49(-55.7%) |
2019 | 21.44(-60.1%) |
2018 | 53.69 |
FAQ
- What is Amneal Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Amneal Pharmaceuticals?
- What is AMRX EV/EBITDA year-to-date change?
- What is Amneal Pharmaceuticals EV/EBITDA year-on-year change?
What is Amneal Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of AMRX is 14.30
What is the all time high EV/EBITDA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high EV/EBITDA is 124.82
What is AMRX EV/EBITDA year-to-date change?
Amneal Pharmaceuticals EV/EBITDA has changed by +0.41 (+2.95%) since the beginning of the year
What is Amneal Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, AMRX EV/EBITDA has changed by +3.22 (+29.06%)